You are here: All Products  > Biosyngen’s IND Accepted in China for T Cell Treatment of Nasopharyngeal Cancer

Biosyngen’s IND Accepted in China for T Cell Treatment of Nasopharyngeal Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products